Literature DB >> 12051963

Novel mutations in domain I of SCN5A cause Brugada syndrome.

Matteo Vatta1, Robert Dumaine, Charles Antzelevitch, Ramon Brugada, Hua Li, Neil E Bowles, Koonlawee Nademanee, Josep Brugada, Pedro Brugada, Jeffrey A Towbin.   

Abstract

Brugada syndrome, an autosomal dominantly inherited form of ventricular fibrillation characterized by ST-segment elevation in leads V1-V3 and right bundle-branch block on surface electrocardiogram, is caused by mutations in the cardiac sodium channel gene SCN5A. Patients with Brugada syndrome were studied using single-strand conformation polymorphism analysis, denaturing high-performance liquid chromatography, and DNA sequencing of SCN5A. Mutations were identified in SCN5A in two families and one sporadic case. In one family, a missense mutation leading to a glycine to valine substitution (G351V) in the pore region between the DIS5 and DIS6 transmembrane segments was detected. Biophysical analysis demonstrated that this mutation caused significant current reduction. In the other family, a 20-bp deletion of the exon 5 splice acceptor site was identified; as exon 5 encodes part of the intracellular loop between DIS2 and DIS3, this portion of the channel is disrupted. In the sporadic patient, a missense mutation resulting in the substitution of lysine by glutamic acid (K126E) in the intracellular loop at the boundary with DIS1 was identified. These three new SCN5A mutations in Brugada syndrome patients are all located within domain I of SCN5A, a region not previously considered important in the development of ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051963     DOI: 10.1016/S1096-7192(02)00006-9

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

1.  A sodium channel pore mutation causing Brugada syndrome.

Authors:  Arnold E Pfahnl; Prakash C Viswanathan; Raul Weiss; Lijuan L Shang; Shamarendra Sanyal; Vladimir Shusterman; Cari Kornblit; Barry London; Samuel C Dudley
Journal:  Heart Rhythm       Date:  2006-09-28       Impact factor: 6.343

2.  Solution NMR structure of the C-terminal EF-hand domain of human cardiac sodium channel NaV1.5.

Authors:  Benjamin Chagot; Franck Potet; Jeffrey R Balser; Walter J Chazin
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

Review 3.  Genetics of sudden cardiac death.

Authors:  Alon Barsheshet; Andrew Brenyo; Arthur J Moss; Ilan Goldenberg
Journal:  Curr Cardiol Rep       Date:  2011-10       Impact factor: 2.931

Review 4.  Brugada syndrome: from cell to bedside.

Authors:  Charles Antzelevitch; Pedro Brugada; Josep Brugada; Ramon Brugada
Journal:  Curr Probl Cardiol       Date:  2005-01       Impact factor: 5.200

5.  Unique mixed phenotype and unexpected functional effect revealed by novel compound heterozygosity mutations involving SCN5A.

Authors:  Argelia Medeiros-Domingo; Bi-Hua Tan; Pedro Iturralde-Torres; David J Tester; Teresa Tusié-Luna; Jonathan C Makielski; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2009-05-04       Impact factor: 6.343

6.  Cardiac Na+ current regulation by pyridine nucleotides.

Authors:  Man Liu; Shamarendra Sanyal; Ge Gao; Iman S Gurung; Xiaodong Zhu; Georgia Gaconnet; Laurie J Kerchner; Lijuan L Shang; Christopher L-H Huang; Andrew Grace; Barry London; Samuel C Dudley
Journal:  Circ Res       Date:  2009-09-10       Impact factor: 17.367

7.  Characterization of N-terminally mutated cardiac Na(+) channels associated with long QT syndrome 3 and Brugada syndrome.

Authors:  Christian Gütter; Klaus Benndorf; Thomas Zimmer
Journal:  Front Physiol       Date:  2013-06-26       Impact factor: 4.566

Review 8.  Experimental Models of Brugada syndrome.

Authors:  Franziska Sendfeld; Elisabet Selga; Fabiana S Scornik; Guillermo J Pérez; Nicholas L Mills; Ramon Brugada
Journal:  Int J Mol Sci       Date:  2019-04-29       Impact factor: 5.923

Review 9.  Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Authors:  Gildas Loussouarn; Damien Sternberg; Sophie Nicole; Céline Marionneau; Francoise Le Bouffant; Gilles Toumaniantz; Julien Barc; Olfat A Malak; Véronique Fressart; Yann Péréon; Isabelle Baró; Flavien Charpentier
Journal:  Front Pharmacol       Date:  2016-01-14       Impact factor: 5.810

10.  Feasibility of an Assessment Tool for Children's Competence to Consent to Predictive Genetic Testing: a Pilot Study.

Authors:  Irma M Hein; Pieter W Troost; Robert Lindeboom; Imke Christiaans; Thomas Grisso; Johannes B van Goudoever; Ramón J L Lindauer
Journal:  J Genet Couns       Date:  2015-04-26       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.